Seattle Genetics | Créances Commerciales

Trade Debtors Changement Date
AbbVie USD 11.41B 79M 2023-09
Acadia Pharmaceuticals USD 102.35M 7.82M 2023-12
Agios Pharmaceuticals USD 2.81M 1.63M 2023-12
Amgen USD 7.27B 1.12B 2023-12
Bayer EUR 14.25B 3.11B 2023-09
Celldex Therapeutics USD 2.63M 2.38M 2023-12
Eisai JPY 191.91B 2.7B 2023-09
Eli Lilly USD 10.36B 1.19B 2023-09
Exelixis USD 248.11M 15.3M 2023-09
Genmab DKK 5.43B 618M 2023-09
Gilead Sciences USD 4.66B 130M 2023-12
GlaxoSmithKline GBP 8.87B 1.78B 2023-09
Incyte USD 743.56M 86.29M 2023-12
Insmed USD 41.19M 5.61M 2023-12
Moderna USD 1.08B 1.07B 2023-12
Pfizer USD 15B 1.58B 2023-09
Regeneron Pharmaceuticals USD 5.67B 82.8M 2023-12
Sarepta Therapeutics USD 354.26M 87.1M 2023-09
Takeda JPY 788.07B 37.42B 2023-09
Teva Pharmaceutical Industries USD 3.38B 154M 2023-09
Vertex Pharmaceuticals USD 1.54B 17.5M 2023-09
Xencor USD 11.29M 43.71M 2023-12



Seattle Genetics Créances Commerciales - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.